Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: J Appl Toxicol. 2017 Jan 31;37(7):873–883. doi: 10.1002/jat.3436

Table 1.

Cytotoxicity determination of isolates from Castela macrophylla and standard of care agents

Compound Cell Lines
CCD18 Co HT29 MCF-10A MCF-7
(−)-Glaucarubolone NI NI NI NI
(−)-Holacanthone <5 9.91 ± 0.52 0.3 ± 1.25 11.031 ± 1.13
(−)-Glaucarubolone
glucoside
40.14 ± 3.41 NI NI 8.65 ± 1.11
Scopoletin NI 19.28 ± 0.348 NI NI
Tamoxifen ND ND 38.9 ± 1.19 17.28 ± 0.06
5-Fluorouracil 55.51 ± 3.71 23.50 ± 1.12 NI 78.6 ± 1.73
Doxorubicin ND ND 30.2 ± 1.29 NI

Cells were exposed to the isolates or anticancer agents (1 nM-100 μM) for 24 h before cytotoxicity analysis using the MTS or the Alamar Blue assay. IC50 represents the concentration needed to inhibit the growth of cancer cells by 50%. These values (μM) were obtained from the interaction of isolates with various cancer and normal cell lines along with positive controls (standard of care agents Tamoxifen, Fluorouracil and Doxorubicin), as outlined in Materials and Methods. Results are represented as the mean of at least three independent experiments ±SEM. Key: NI: No inhibition (<10% inhibition at 60 μM), ND: Not determined.